1. Abdolmaleky, H. M., Cheng, K. H., Faraone, S. V., Wilcox, M., Glatt, S. J., Gao, F., et al. (2006). Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Human Molecular Genetics, 15(21), 3132–3145.
2. Aguirre-Samudio, A. J., & Nicolini, H. (2005). DRD4 polymorphism and the association with mental disorders. Revista de Investigacion Clinica, 57(1), 65–75 (article in Spanish).
3. Ahveninen, J., Kahkonen, S., Tiitinen H., Pekkonen E., Huttunen J., Kaakkola S., et al. (2000). Suppression of transient 40-Hz auditory response by haloperidol suggests modulation of human selective attention by dopamine D2 receptors. Neuroscience Letters, 292, 29–32.
4. Alfimova, M., Golimbet, V., Gritsenko, I., Lezheiko, T., Abramova, L., Strel’tsova, M., et al. (2006). Dopamine system genes interaction and neurocognitive traits in patients with schizophrenia, their relatives and healthy controls from general population. Zhurnal Nevrologii i Psikhiatrii Imeni S S Korsakova, 106, 57–63 (article in Russian).
5. Avale, M. E., Falzone, T. L., Gelman, D. M., Low, M. J., Grandy, D. K., & Rubinstein, M. (2004). The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder. Molecular Psychiatry, 9(7), 718–726.